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ABSTRACT
Survival motor neuron (SMN) functions in the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs) that catalyze
pre-mRNA splicing. Here, we used disruptions in Smn and two additional snRNP biogenesis genes, Phax and Ars2, to classify RNA
processing differences as snRNP-dependent or gene-specific in Drosophila. Phax and Smn mutants exhibited comparable
reductions in snRNAs, and comparison of their transcriptomes uncovered shared sets of RNA processing changes. In contrast,
Ars2 mutants displayed only small decreases in snRNA levels, and RNA processing changes in these mutants were generally
distinct from those identified in Phax and Smn animals. Instead, RNA processing changes in Ars2 mutants support the known
interaction of Ars2 protein with the cap-binding complex, as splicing changes showed a clear bias toward the first intron.
Bypassing disruptions in snRNP biogenesis, direct knockdown of spliceosomal proteins caused similar changes in the splicing
of snRNP-dependent events. However, these snRNP-dependent events were largely unaltered in three Smn mutants expressing
missense mutations that were originally identified in human spinal muscular atrophy (SMA) patients. Hence, findings here
clarify the contributions of Phax, Smn, and Ars2 to snRNP biogenesis in Drosophila, and loss-of-function mutants for these
proteins reveal differences that help disentangle cause and effect in SMA model flies.
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neuron; SMN; spinal muscular atrophy; SMA; phosphorylated adaptor for RNA export; PHAX; Ars2; Prp6; Prp8; RNA-sequencing;
snRNA; snRNP biogenesis
INTRODUCTION
Survival motor neuron (SMN) protein functions in the
assembly of Sm-class small nuclear ribonucleoproteins
(snRNPs), core components of the spliceosome (Fischer
et al. 2011; Matera and Wang 2014). Loss of SMN causes
the neuromuscular disease spinal muscular atrophy (SMA)
(Lefebvre et al. 1995), but the extent to which SMA is caused
by disruptions in snRNP levels is not known. Loss of SMN
causes transcriptome-wide changes in gene expression and
RNA processing that are often assumed to stem from down-
stream disruptions in snRNP supply (Zhang et al. 2008, 2013;
Garcia et al. 2013), but direct transcriptomic comparisons of
SMA models with other targeted disruptions in snRNP bio-
genesis genes have, to date, not been performed.
The nuclear export of Sm-class small nuclear RNAs
(snRNAs) is a key step in snRNP biogenesis. Sm-class
snRNPs catalyze pre-mRNA splicing in the nucleus, but
some steps of snRNP biogenesis occur in the cytoplasm, in-
cluding assembly by SMN and associated SMN complex pro-
teins (Matera and Wang 2014). The phosphorylated adaptor
for RNA export protein (PHAX) mediates the nuclear export
of newly transcribed snRNAs by linking them to the Exportin
1 (XPO1/CRM1) nuclear export machinery (Ohno et al.
2000). PHAX interacts with the 5′-terminal cap binding com-
plex (CBC) and adjacent 5′-proximal RNA of RNA polymer-
ase II transcripts, but it is displaced from longer mRNAs
by the heterogeneous nuclear ribonucleoprotein C (C1/C2)
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tetramer (Ohno et al. 2000; McCloskey et al. 2012; Ohno
2012). Hence, PHAX functions to selectively export smaller
snRNAs with lengths approximately 100 to 250 nucleotides
(nt), making it an attractive target for genetically manipulat-
ing snRNP levels.
The nuclear export of Sm-snRNAs follows transcription
termination. Prior to nuclear export, snRNAs are cotran-
scriptionally cleaved from downstream sequences. Unlike
mRNAs, snRNAs are cleaved but not polyadenylated
(Matera and Wang 2014). The Integrator is a multiprotein
complex that cleaves snRNAs to form 3′-ends that lack a
poly(A) tail (Baillat et al. 2005; Baillat and Wagner 2015).
Proper 3′-end maturation of snRNAs is cotranscriptionally
linked to upstream promoter sequences and 5′-ends (de
Vegvar et al. 1986; Hernandez and Weiner 1986; Ezzeddine
et al. 2011). Recently, the CBC-binding protein arsenite resis-
tance protein 2 (ARS2/SRRT) was implicated in this cross-
talk between snRNA 3′- and 5′-ends (Hallais et al. 2013).
Knockdown of ARS2 or CBC proteins in mammalian cells
increased readthrough of endogenous snRNAs and snRNA
3′-end reporters (Andersen et al. 2013; Hallais et al. 2013).
In addition to snRNA 3′-end maturation, ARS2 contributes
to the 3′-end maturation of replication-dependent histone
mRNAs, at least in mammals, and it also has a conserved
role in the regulation of microRNA biogenesis (Grigg et al.
2005; Lobbes et al. 2006; Yang et al. 2006; Gruber et al.
2009, 2012; Sabin et al. 2009). In this context, ARS2 is likely
a less selective target than PHAX for disrupting the supply
of snRNPs.
Observations in diverse eukaryotes suggest that perturba-
tions in snRNP supply produce transcriptome-wide effects,
particularly in alternative splicing and polyadenylation.
Mutations in yeast genes encoding core spliceosomal factors
disrupted the splicing of a subset of pre-mRNAs, including
splicing events in highly expressed pre-mRNAs for ribosomal
protein genes (RPGs) (Clark et al. 2002; Pleiss et al. 2007).
Inversely, repressing the transcription of these highly ex-
pressed RPGs changed the alternative splicing patterns of
other yeast pre-mRNAs, suggesting that spliceosomal accessi-
bility controls pre-mRNA splicing patterns (Munding et al.
2013). In Drosophila, core splicing factors were uncovered
by an RNAi screen for regulators of a predetermined set of
alternative-splicing patterns (Park et al. 2004). In cultured
human cells, knockdown of Sm-class snRNP-associated
proteins led to numerous changes in alternative splicing
(Saltzman et al. 2011). Furthermore, blocking U1 snRNP
specifically with an antisense morpholino led to prema-
ture cleavage and polyadenylation of mRNAs in cells from
diverse lineages (Kaida et al. 2010; Berg et al. 2012). These
studies highlight that multiple strategies can be used to
effectively disrupt snRNP supply and function, which creates
an opportunity to use comparative transcriptomics to
comprehensively categorize the snRNP dependence and/or
spliceosomal accessibility requirements of disparate RNA
processing events.
Here, we carried out transcriptome profiling of Drosophila
Smn mutants, along with two additional snRNP biogenesis
mutants in order to identify snRNP-dependent versus
gene-specific changes in gene expression, premature cleavage
and polyadenylation, and alternative splicing. Specifically,
transposon insertion mutations in the fly orthologs of Phax
and Ars2 were used for comparison with Smn null mutants
(Ohno et al. 2000; Kitao et al. 2008; Laubinger et al. 2008;
Gruber et al. 2009; Andersen et al. 2013; Hallais et al. 2013;
Pabis et al. 2013). The Phax mutant was particularly useful
in identifying an overlapping set of snRNP-dependent RNA
changes in SMA model flies, and the analysis of the Ars2
mutants revealed a distinct set of RNA processing events
that likely depend on the integrity of the CBC and 5′-cap.
Additionally, alternative-splicing differences shared between
the Phax and Smn mutants could be rescued at both the
RNA and protein levels by expression of Phax or Smn trans-
genes, respectively. In combination with a modest restoration
of steady-state snRNA levels, observations from these rescue
lines corroborate the connection between snRNP levels and
specific pre-mRNA splicing events. However, the link be-
tween these changes and SMA phenotypes remains unclear.
RESULTS
Phax and Smn mutants display similar steady-state
snRNA decreases
RNA-sequencing (RNA-seq) of poly(A)-selected RNA was
used to identify mRNA changes in snRNP biogenesis mu-
tants, and Northern analysis coupled with RNA-seq of total
ribosomal RNA-subtracted (rRNA−) RNAwas used to quan-
tify steady-state snRNA levels. Browser shots of Phax, Smn,
and Ars2 gene loci confirmed the gene disruptions in the
respective mutant lines (Fig. 1A; Garcia et al. 2013). In our
previous RNA-seq analysis of Smn null mutants, publicly
available modENCODE data were used to determine the
developmental stage at which the mutants arrested (Garcia
et al. 2013). By the same method, the Phax and Ars2mutants
exhibited a similar timing of developmental delay as did the
Smn animals (Supplemental Fig. S1A,B). Using developmen-
tally appropriate wild-type controls (Supplemental Fig. S2A),
Northern blots demonstrated comparable, near twofold de-
creases in steady-state U1, U2, and U4 snRNAs in the Phax
and Smn mutants (Fig. 1B,C). When assayed by Northern
blotting, U5 snRNA levels were essentially unaffected in the
Phax mutants (Fig. 1B,C), as were levels of nearly all of the
snRNAs in the Ars2 mutants (Fig. 1B,C). When RNA-seq
data were used to quantify snRNA levels, each of the three
mutants appeared to exhibit snRNA deficits, but the extent
varied by the method of normalization (Supplemental
Fig. S2B,C). Only small (<15%) changes were observed in
specific snRNA paralogs relative to the total (Supplemental
Fig. S3), quantified by using reads covering isoform-specific
nucleotides (Lu andMatera 2014). Overall, the Phax and Smn
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mutants displayed the most consistent decreases in steady-
state snRNA levels.
snRNP biogenesis mutants share a small number
of gene expression changes
To identify shared and distinct changes in gene expression
between snRNP biogenesis mutants, we used the TopHat/
Cufflinks pipeline to quantify mRNA differences from our
poly(A)-selected RNA-seq data (Trapnell et al. 2012). Raw
reads from age-matched wild-type (WT) controls and
modENCODE second (L2) and early third instar (L3 12h)
developmental controls were integrated with sequencing
data from the mutants into a single analytical pipeline. For
comparison, we focused on genes whose expression changed
uniformly and significantly (false discovery rate-adjusted P-
value <0.05) relative to each of the controls (L2, L3 12h,
and our WT). A relatively small number of genes and undif-
ferentiated loci with multiple genes (186 out of ∼15,000) met
these stringent criteria for differential expression (i.e., 186
loci were significantly different from all of the controls; total
number from Supplemental Table S1), and most of these dif-
ferences were mutant specific (Fig. 2A,C; Supplemental
Tables S1–S4). A number of stress-responsive transcripts
were among those that were specifically elevated in Smnmu-
tants, though some of these were also up
slightly in the Ars2 mutants (Fig. 2B).
Phax mutants shared only 28 gene ex-
pression changes with Smn mutants
(Fig. 2C; Supplemental Table S2). This
small list of genes was enriched for
genes involved in oxidation–reduction,
as measured by DAVID gene ontology
term analysis (P-value = 0.003) (Huang
et al. 2007, 2009a,b). A notable gene
expression change shared by the Phax
and Smn mutants was a fivefold in-
crease in the Activity-regulated cytos-
keleton associated protein 1 (Arc1)
transcript (Supplemental Table S2).
Arc1 functions in a well conserved hyper-
locomotion response to starvation, and
hence elevated levels in Phax and Smn
mutants might be an indirect conse-
quence of a disruption in nutrient acqui-
sition in these animals (Mattaliano et al.
2007). In summary, gene expression
analysis uncovered a small number of
overlapping changes that exceeded nor-
mal developmental fluctuations. The
relationship of these changes to SMA
etiology and/or pathology remains to be
determined.
snRNP biogenesis mutants exhibit a trend toward
shorter mRNAs
In addition to its role in splicing, U1 snRNP has been report-
ed to control mRNA length by preventing premature cleavage
and polyadenylation (Kaida et al. 2010; Berg et al. 2012).
To determine whether reduced U1 snRNA levels in our
snRNP biogenesis mutants correlated with expression of
shorter mRNAs, mapped RNA-seq reads were analyzed using
the DaPars linear regression algorithm (Masamha et al. 2014;
Xia et al. 2014). DaPars output is displayed as a percentage of
distal poly(A) site usage index (PDUI) for each transcript, or
as the difference in the PDUI value between wild-type and
mutant (ΔPDUI). Pairwise comparisons of PDUI values for
wild-type and mutants can be used to visualize changes in
RNA length. Whereas the Phax and Smn mutants expressed
transcripts that were both longer and shorter than their
wild-type counterparts, there were greater numbers of short-
ened mRNAs (Fig. 3A–C; Supplemental Tables S5–S7).
Focusing on differences that are greater than twofold, Phax
and Smn mutants had a relatively small number of mRNA
length changes in common with each other (34) (Supple-
mental Table S5). However, the changes were largely distinct
from those observed in Ars2 animals, who had more than
twice as many mRNA length changes as did the Phax and
Smn mutants combined (Fig. 3D; Supplemental Table S8).
FIGURE 1. Analysis of three different snRNP biogenesis mutants. (A) Browser shots of larval
RNA-seq reads at the three disrupted gene loci. Reads from Oregon-R (WT) versus PhaxSH/SH,
SmnX7/D, or Ars2C/E snRNP biogenesis mutants are shown. Mapped read tracks were normalized
to the median of the middle two quartiles of the mappedWT sequence read counts. (B) Northern
blot of RNA from snRNP biogenesis mutants andWT larvae. RNAwas extracted fromWT larvae
at 60 ± 2 h (60 h) post egg-laying, and mutant RNA was extracted at 74 ± 2 h to account for their
delayed development (see text). (C) Quantification of Northern blot in B. Sm-class snRNAs were
normalized to the Lsm-class U6 snRNA, and U6-normalized WT snRNA levels were set at 100.
Asterisks are P-values from a Student’s t-test: (∗) P-value ≤0.05, (∗∗) P-value ≤0.01, (∗∗∗) P-value
≤0.001.
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The individual direction of length change, either longer or
shorter, was also factored into the consideration of overlap-
ping differences in Figure 3D. The overall trend of shorter
transcripts in the mutants does not appear to be a conse-
quence of developmental delay, as parallel DaPars analyses
of modENCODE data sets of second to third instar larvae
showed a trend toward shorter transcripts in the more ma-
ture animals (Supplemental Fig. S4). Among the few overlap-
ping mRNA length changes between Phax and Smn, one of
the largest and most apparent changes was a shortened
mRNA for CG9662, a putative oligosaccharyl transferase
complex subunit (ΔPDUI =−0.96, Supplemental Table
S5). These results are generally consistent with the notion
that reductions in U1 snRNP levels predispose mRNAs
to premature cleavage and polyadenylation. Because the
Ars2 mutants exhibited only a small decrease in steady state
U1 levels (<10%; Fig. 1C), the mRNA length changes in
these animals are more likely due to disruptions of the
CBC, which are known to affect a subset of pre-mRNA termi-
nation events (Wong et al. 2007; Andersen et al. 2013; Hallais
et al. 2013).
Phax and Smn mutants share a set of alternative
splicing pattern changes
Our previous RNA-seq analysis of Smn null animals revealed
many small-amplitude alternative splicing differences (com-
pared to wild-type controls), but it was unclear whether any
of these changes might be due to decreases in snRNP levels
(Garcia et al. 2013). To ascertain whether any of these splic-
ing changes are snRNP-dependent, we used the mixture of
isoforms (MISO) probabilistic framework to compare splic-
ing differences in Smnmutants with those identified in Phax
and Ars2 mutants (Katz et al. 2010). Simply put, the MISO
algorithm estimates the expression of alternatively spliced
isoforms in RNA-seq data, and reports it as a fraction of
alternatively spliced events relative to the total (Katz et al.
2010). MISO denotes this fraction as the “percent spliced
in” or “Psi” (Katz et al. 2010). Differences are reported
here as an absolute change relative to the wild-type control,
|deltaPsi|. Similar to our previous results with the Smn null
animals, we found mostly small changes (less than twofold,
|deltaPsi| <0.5) in alternative-splicing events in the Phax
and Ars2 mutants (Fig. 4A–C; Supplemental Tables S9–
S11). More than half of the splicing changes identified in
the Smn null animals overlapped with changes in the Phax
mutants, but neither the Phax nor Smnmutants had consid-
erable overlap with those observed in the Ars2 mutants (Fig.
4D; Supplemental Table S11). Of the top 150 differences in
the Ars2 background, close to 90% of these changes were lo-
cated in the 5′-proximal intron (Supplemental Table S11).
These changes likely reflect the association of Ars2 with the
CBC and the role of this complex in promoter proximal
splicing events (Laubinger et al. 2008) rather than Ars2-relat-
ed changes in snRNPs. In contrast, the changes that were
common to Phax and Smn mutants are more likely to be
due to decreases in snRNP levels.
FIGURE 2. Gene expression differences in snRNP biogenesis mutants.
(A) Heatmap comparison of Cuffdiff FPKM levels of differentially
expressed transcripts. Heatmap colors were rescaled for each row
and the rows were clustered based on pattern of gene expression
between WT and mutants. (B) A heatmap of FPKMs from a set of
stress-responsive transcripts in A. (C) Venn diagram of the overlap in
gene expression differences in the snRNP biogenesis mutants. Phax =
PhaxSH/SH, Smn = SmnX7/D, and Ars2 = Ars2C/E. Numbers in parenthe-
ses are totals.
FIGURE 3. mRNA length changes in snRNP biogenesis mutants.
Pairwise comparison of significant (false discovery rate adjusted P-value
<0.05) differences in mRNA length between WT and PhaxSH/SH (A);
WT and SmnX7/D (B); andWT and Ars2C/E (C). RNA length differences
were extracted frommapped RNA-seq read files by the DaPars linear re-
gression algorithm (see text). Percentage of distal poly(A) site usage in-
dex = PDUI. (D) Venn diagram of RNA length differences in snRNP
biogenesis mutants labeled as in Figure 2.
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Transgenic rescue of alternative splicing changes
induced by loss of Phax or Smn
As described previously, Smn is essential for viability in the fly
(Chan et al. 2003), and transgenic expression of Flag- or
GFP-tagged SMN protein in an otherwise null mutant back-
ground fully rescues the larval lethality and other SMA-like
phenotypes (Rajendra et al. 2007; Shpargel et al. 2009).
Here, we found that Phax is also an essential gene, and that
ectopic expression of Phax-GFP using the GAL4-UAS system
rescued the lethality of PhaxSH/SH mutants (Supplemental
Table S12). We next assayed (and confirmed by semi-quan-
titative RT-PCR) a number of the most apparent alternative
splicing changes identified by RNA-seq (Supplemental Fig.
S5). We then tested the ability of the Phax and Smn trans-
genes to rescue four of these splicing events by quantitative
qRT-PCR (Fig. 5B,C). Ubiquitous expression of Phax using
an Armadillo-GAL4 driver significantly rescued all of the
splicing changes we tested (Fig. 5B). Transgenic expression
of Smn, driven by its native promoter, also rescued these al-
ternative-splicing events in Smn null animals (Fig. 5C).
Together, the results confirm that the observed changes we
identified by RNA-seq are indeed caused by loss of Phax or
Smn expression.
One of the splicing changes we detected is expected to pro-
duce an alternative (larger) dUTPase protein isoform.
Therefore, we assayed the impact of this alternative splicing
change by Western blotting, using an antibody that targets
both dUTPase isoforms. As shown in Figure 5D, the expected
increase in the ratio of the long isoform relative to the short
one was observed in the mutants, and this change was largely
rescued in both transgenic lines. Thus, the transcriptomic
changes we identified in SMA model animals can (and do)
translate into detectable differences at the protein level.
An increase in steady-state snRNA
levels correlates with rescue of
alternative splicing
If the alternative splicing changes, ob-
served in both Phax and Smn mutants,
are truly caused by the decreased
availability of snRNPs, then rescue of
steady-state snRNA levels should mirror
the rescue of these alternative splicing
changes in the Phax and Smn transgenic
lines. Northern blotting was used to de-
termine whether the expression of Phax
and Smn transgenes increased steady-
state snRNA levels in the mutants
(Supplemental Fig. S6A,B). Expression
of the Phax transgene by the Armadillo
driver significantly rescued U1 and U4
snRNA levels in the PhaxSH/SH mutant
background (Supplemental Fig S6A,B).
All of the snRNAs tested here were
significantly rescued by expression of
the wild-type Smn transgene in the Smn null background
(Supplemental Fig. S6C,D). For the wild-type Smn rescue
line, these observations differ from our previously published
results (Praveen et al. 2012), wherein we detected a modest
increase in snRNA levels in the rescue line. This difference
likely reflects minor improvements to our Northern blotting
protocol, specifically: using less total RNA per gel lane and
more labeled probe in the hybridization reaction to ensure
probe excess. The increases in steady-state snRNA levels
that we observed in the Phax and Smn rescue lines correlated
well with the phenotypic rescue at both the organismal (via-
bility) and molecular (alternative splicing) levels.
Splicing changes shared between Phax and Smn
mutants are also caused by knockdown of splicing
factors Prp6 and Prp8
Although the correlation of snRNA levels with particular
splicing events provides evidence that these events are acutely
sensitive to disruption of the core spliceosomal machinery,
it does not rule out other possibilities. For example, the
covariance could be due to a direct interaction of splicing
factors with Phax and SMN, or a result of indirect factors,
such as altered developmental progression. In addition,
snRNPs are well known to be stable RNPs, and we do not
know at what point reductions in ongoing snRNP supply
begin to impair spliceosomal function. To test whether the
splicing changes in the Phax and Smn mutants are indeed
linked to a reduction in snRNP supply and a corresponding
disruption in spliceosome function, we depleted the tri-
snRNP and U5-associated proteins Prp6 and Prp8 using
RNA interference. As shown in Figure 6A–C, SMN deple-
tion caused a slight (less than twofold) perturbation in the
FIGURE 4. Alternative-splicing differences among snRNP biogenesis mutants. Distribution of
significant alternative-splicing changes from small |delta Psi| near zero to large |delta Psi| near
one: (A) PhaxSH/SH mutants relative to WT; (B) SmnX7/D mutants relative to WT; and (C)
Ars2C/E mutants relative to WT. (D) Venn diagram of overlapping alternative-splicing changes
in snRNP biogenesis mutants, labeled as in Figure 2.
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splicing events tested, but the Prp6 and Prp8 knockdowns
disrupted the splicing of these transcripts to a much greater
extent. Knockdown of Prp8 disrupted the splicing of the
events identified above (Abi, αCOP, dUTPase, and Rpn2 in-
tron 1 [int. 1]), but it did not significantly disrupt the splicing
of a downstream intron in Rpn2, serving here as a control for
broader spliceosomal dysfunction. The Prp6 and Prp8 knock-
downs also altered dUTPase protein expression patterns
to a greater extent than did knockdown of Smn (Fig. 6B).
Steady-state snRNA levels were not significantly affected
by any of these knockdowns, with the possible exception of
U5 snRNA, which was slightly reduced (∼40%) in the Prp8
depletion (Fig. 6D,E). The lack of snRNA decreases in the
SMN depleted samples is consistent with the well-known
perdurance of snRNPs in cultured cells, and it likely mir-
rors the observed low-amplitude disruptions to splicing.
Prp6 and Prp8 are core spliceosomal proteins, and their
depletion is expected to severely compromise the spliceo-
some (Grainger and Beggs 2005; Will and Luhrmann
2011). Thus, the splicing changes seen
in these knockdowns are perhaps not
unexpected, but they nevertheless sup-
port the conclusion that the overlapping
changes identified in the Phax and Smn
null mutants are snRNP dependent.
Hypomorphic Smn missense
mutants rescue snRNP levels and
do not display defects in alternative
splicing
As mentioned, the snRNP biogenesis
mutants described above are severe loss-
of-function alleles. SMA is, however, a
hypomorphic condition, as complete
loss of SMN activity is lethal in all organ-
isms tested. To better model the disease
in the fly, we previously engineered an
allelic series of transgenic animals that
express Smn missense mutations known
to cause SMA in humans (Praveen et al.
2012, 2014). In addition to the wild-
type rescue transgene (SmnWT), we
analyzed three hypomorphic lines that
display intermediate (SMA type II)
phenotypes: SmnT205I, SmnY107C, and
SmnV72G (Praveen et al. 2014). These
lines cover a range of phenotypic out-
comes: SmnT205I is semi-viable (∼30%
eclose as adults), SmnY107C is pharate-
lethal (very few animals eclose), and
SmnV72G mutants all die as pupae
(Praveen et al. 2014). Importantly, in
this system, the wild-type and mutant
transgenes are integrated at the identical
chromosomal locus and are expressed from the native pro-
moter in an otherwise Smn null background (Praveen et al.
2012, 2014). Using qRT-PCR, we analyzed the alternative
splicing patterns of the four transcripts described above. As
shown in Figure 7A, none of the Smnmissense lines exhibited
a greater than twofold change (in either direction) relative to
SmnWT. Consistent with this finding, the missense mutants
also displayed little-to-no difference in steady-state snRNA
levels, compared to the wild-type rescue line (Fig. 7B,C).
To ensure that differences in developmental timing did not
confound the analysis, animals were harvested after they
began to display the wandering behavior that is characteristic
of the late third instar stage of Drosophila development. We
also measured snRNA levels of animals at slightly earlier
and later developmental time points, and we found little
difference between the mutant and the control lines
(Supplemental Fig. S7). Steady-state snRNA differences in
earlier animals may reflect subtle differences in developmen-
tal progression from wild-type controls, but these decreased
FIGURE 5. Transgenic rescue of alternative-splicing changes in Phax and Smn mutants. (A)
UCSC browser shots of mapped read tracks for four of the top 15 identified alternative splicing
changes. (B) qRT-PCR analysis of intron retention in PhaxSH/SH mutants versus PhaxSH/SH mu-
tants expressing aUAS-Phax transgene from the armadillo promoter driven GAL4 (Arm > Phax).
(C) qRT-PCR of intron retention in SmnX7/D mutants versus SmnX7/X7 mutants expressing a
wild-type Smn transgene from its native promoter. For B and C, levels of WT intron retention
were set at one. (D) Western blot for dUTPase. Alternate protein isoforms reflect alternative-
splicing change in dUTPase mRNA. Wild-type Smn transgene in SmnX7/X7 background =
Tg:SmnWT. Long dUTPase protein isoform = PA and short = PB.
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levels were largely absent from the later pupal stage, which
only exhibited significantly lower U4 levels in the single
SmnY107C line.
Smn missense mutants display limited overlap
in splicing pattern changes
The large-amplitude changes identified in the severe loss-of-
function mutants were not evident in the Smn hypomorphs;
however, these lines could exhibit other splicing pattern or
gene expression changes that might account for differences
in their phenotypic outcomes. To identify RNA changes in
the hypomorphic lines, we sequenced total (rRNA-subtract-
ed) RNA from whole animals isolated ∼12 h after puparium
formation, a developmental stage that Smn null animals nev-
er reach. The hypomorphs displayed numerous changes in
their splicing patterns relative to the wild-type rescue line
(1662 combined; Supplemental Tables S13–16). However,
the missense mutants displayed few large amplitude (greater
than twofold) changes (107/1662), and hardly any of these
events were shared between them (42/1662) (Fig. 8A; Sup-
plemental Table S13). Of the forty-two overlapping splic-
ing changes, only six were previously identified as being
snRNP-dependent (four) or Smn gene-specific (two) by
comparison to data from the severe Phax and Smn loss-of-
function lines (Fig. 8B). Browser shots of representative
examples are shown in Figure 7C. We
used qRT-PCR to validate one of the
two Smn gene-specific changes. The scar-
face transcript (Supplemental Fig. S8;
Supplemental Table S13) exhibited an in-
crease in intron retention between the
third and fourth exons in the SmnV72G
transgenic line (deltaPsi =−0.61 and a
>100-fold change by qRT-PCR). In the
fly, Scarface functions as a negative regu-
lator of JNK (c-Jun N-terminal kinase)
stress signaling (Rousset et al. 2010). As
measured by RNA-seq, the SmnY107C
(deltaPsi =−0.23) and SmnT205I (del-
taPsi =−0.07) mutants exhibited smaller
changes; these events were below the lim-
it of detection by qRT-PCR (Supplemen-
tal Fig. S8A; Supplemental Table S13).
Consistent with the notion that this is
not a snRNP-dependent change, an
increase in scarface intron retention was
not observed following knockdown of
Prp8 (Supplemental Fig. S8B). Thus,
RNA-seq profiling of hypomorphic,
SMA-causing missense mutations is in
agreement with the qRT-PCR data de-
scribed above, and together these find-
ings demonstrate that the splicing
changes identified in the Smn null
animals are not conserved among the intermediate SMA
models.
Differential expression analysis reveals an
activation of stress signaling in Smn missense
mutant animals
In addition to changes in splicing patterns, our genome-wide
analysis of RNA from the severe loss-of-function mutants re-
vealed potential snRNP-dependent and Smn gene-specific
changes in steady-state mRNA levels. Differential expression
analysis of the Smnmissense mutant lines revealed numerous
changes in mRNA abundance in the most severe line,
SmnV72G (599), but far fewer in the other less severe lines,
SmnY107C (88) and SmnT205I (59) (Fig. 9A,B; Supplemental
Table S17–S21). Despite the low number of changes in the
least severe SmnT205I line, more than half of these overlapped
with the other hypomorphic mutants (Fig. 9B). Surprisingly,
many of the stress-responsive transcripts identified in the
severe Smn null mutants were also among the mRNAs that
were up-regulated in all three Smn transgenic lines, relative
to the wild-type rescue line (Fig. 9C; Supplemental Table
S18). As corresponding increases in mRNA levels were not
found in the Phax mutants (Fig. 2B), these events were clas-
sified as Smn gene-specific. Thus, unlike the snRNP-depen-
dent splicing changes (which are not conserved in the Smn
FIGURE 6. snRNP-specific protein knockdown in S2 cells. (A) qRT-PCR of untreated cells ver-
sus those treated with dsRNA for Smn, Prp6, or Prp8mRNAs. (B) Western blot of dUTPase levels
in RNAi-treated cells. Anti-SMN and anti-α-tubulin verify SMN knockdown and load, respec-
tively. (C) qRT-PCR verification of Prp6 and Prp8mRNA knockdowns. Levels in untreated cells
were set at 100. (D) Northern blot of snRNA levels from S2 cell knockdowns, quantified in
E. U6-normalized snRNA levels of WT were set at 100.
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hypomorphs), the intermediate models of SMA exhibited
clear RNA signatures of stress that correlate with disease
severity (Fig. 9C) and are independent of decreases in
snRNP supply (Fig. 2B).
DISCUSSION
Connecting SMA pathology to SMN’s function in snRNP
assembly and downstream expression of specific mRNA
isoforms remains a necessary benchmark for defining
how splicing changes might contribute to disease etiology.
Therefore, a first step toward uncovering the molecular
mechanisms that elicit SMA outcomes would be to separate
snRNP-dependent phenotypes from those that are SMN spe-
cific. Transcriptomic profiling of Smn and Phax mutants
enabled us to identify a robust set of snRNP-dependent alter-
native splicing changes in SMA model flies. We show that
reductions in steady-state snRNA levels correlate with the
appearance of these alternative-splicing events, and that
rescue of snRNA levels in transgenic animals correlates
with the restoration of normal splicing. Furthermore, deple-
tion of core splicing factors (Prp8 or Prp6) essentially bypass-
es the snRNP depletion step, causing many of the same
alternative-splicing changes. Together, these observations
support a close connection between snRNP levels and proper
gene expression in vivo. Whether or not disruptions to this
ubiquitously required process contribute to SMA phenotypes
is less clear.
Ars2, 5′ exons, and U1 telescripting
Changes in splicing and mRNA length in Phax and Smn an-
imals were largely distinct from the more abundant changes
in the Ars2 mutants (Figs. 3D, 4D). Ars2 is a component of
the 5′ cap binding complex (CBC), and this association
may underlie the transcriptomic changes that we identified
in this mutant (Gruber et al. 2009; Gonatopoulos Pournatzis
and Cowling 2014). The Ars2 splicing changes were mostly in
5′-proximal introns, and this finding is consistent with CBC
mutants in yeast, Xenopus, and plants (Gonatopoulos Pour-
natzis and Cowling 2014). The association of Ars2 with the
CBC likely also underlies the numerous mRNA shortening
events we observed. These findings are consistent with previ-
ous studies in yeast and human cells that suggest the CBC
protects a subset of weak poly(A) signals from premature
cleavage and termination (Wong et al. 2007; Andersen
et al. 2013; Hallais et al. 2013). Importantly, both types of
Ars2 dependent mRNA processing events were largely dis-
tinct from the snRNP-dependent changes observed in the
Phax and Smn mutants.
The distinct mRNA processing changes in Ars2 mutants
may also reflect species-specific differences in the role of
the CBC and Ars2. Unlike ARS2 knockdown experiments
in mammalian cells (Gruber et al. 2012; Hallais et al.
2013), we did not observe defects in snRNA or histone
FIGURE 7. Analysis of steady-state snRNA levels and alternative splic-
ing of target genes in SMN missense mutants. (A) qRT-PCR analysis of
intron retention of flies expressing SMA patient-derived missense mu-
tations. Transgenic animals of the following generalized genotype
were used: SmnX7/X7, Flag-SmnTg/−, where Tg represents a WT, V72G,
Y107C, or T205I transgene. Intron retention in the SmnWT transgenic
rescue line was set at one. (B) Northern blots of snRNA levels in the mis-
sense mutant lines. (C) Quantification of snRNA levels from panel B.
RNA levels in the SmnWT (WT) transgenic line were set at 100.
FIGURE 8. Alternative splicing changes in Smn missense mutants. (A)
Venn diagram of overlapping alternative-splicing changes in Smn mis-
sense mutants. (B) Venn diagram of the overlap in shared splicing dif-
ferences in the Smn missense mutants with either snRNP-dependent
changes or Smn gene-specific changes categorized by comparison of
the Phax and Smn total rRNA(−) RNA-seq. (C) Browser shot examples
of an Smn gene-specific change in alternative-splicing in scarface (top) or
a snRNP-dependent change in CG43394 within a PAPLA1 intron on the
opposite strand (bottom). Genotypes are labeled by SmnTg, which was
expressed in the SmnX7 null background.
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mRNA processing. This finding is consistent with the obser-
vation that Ars2 protein is dispensable for proper histone
mRNA maturation in Drosophila cells (Sabath et al. 2013),
and it suggests that aspects of Ars2 function are not conserved
between vertebrates and invertebrates.
Our identification of a large number of mRNA shortening
events that are shared between Phax and Smn mutants sup-
ports a recently discovered role for the U1 snRNP in the pro-
tection of pre-mRNAs from premature cleavage and
polyadenylation (PCPA). PCPA was previously observed by
subtractive hybridization PCR, coupled with high-through-
put sequencing of RNA from cells treated with antisense olig-
omers targeting the 5′-end of U1 snRNA (Kaida et al. 2010;
Berg et al. 2012). This protective role for U1 snRNPs was
termed “telescripting” (Kaida et al. 2010; Berg et al. 2012)
and our study is the first to validate this process outside of
cell culture models. Although we observed an overall trend
toward shorter transcripts in our data sets (Fig. 3), we found
only a few large-magnitude (greater than twofold) changes
(Supplemental Table S2). This is perhaps unsurprising, given
that treatment of cultured cells with relatively high concen-
trations of anti-U1 oligomers provides an acute and nearly
complete inhibition of U1 snRNA function, whereas the mu-
tations in Phax and Smn do not perturb U1 to the same ex-
tent in the mutant animals.
RNA signatures of disease
Alternative splicing depends on the regulated accessibility of
pre-mRNAs to the spliceosome. Studies in a variety of eu-
karyotes have shown that changing this accessibility, either
directly or indirectly, alters the splicing patterns of specific
pre-mRNAs (Clark et al. 2002; Park et al. 2004; Pleiss et al.
2007; Saltzman et al. 2011; Munding et al. 2013). The extent
to which snRNP levels contribute to normal splicing regula-
tion and/or disease pathology is still being worked out; how-
ever, changes in the pattern of alternative-splicing have been
reported in various SMA model systems (Zhang et al. 2008,
2013; Bäumer et al. 2009; Lotti et al. 2012). The splicing
changes reported in these SMA models are typically assumed
to stem directly from loss of SMN and snRNPs, but such
changes are often difficult to distinguish from broad, indirect
effects of disease pathology or developmental delay (Bäumer
et al. 2009; Garcia et al. 2013). By identifying overlapping
splicing changes in Phax and Smn mutants, we are now
able to distinguish between snRNP-dependent changes and
gene-specific effects.
Many of the alternative splicing changes shared by Phax
and Smn occur in genes of known importance to neuromus-
cular biology. For example, the mammalian ortholog of the
αCOP protein has a demonstrated interaction with SMN,
and it colocalizes with SMN in neuronal projections (Peter
et al. 2011; Custer et al. 2013). This interaction was recently
shown to be required for neurite outgrowth in mammalian
cell and zebrafish models of SMA (Li et al. 2015). Orthologs
of the Abi protein appear to have important roles in neuro-
genesis via the regulation of actin dynamics (Proepper et al.
2007; Lin et al. 2009; Liebau et al. 2011). Dominant muta-
tions in GARS cause the distal neuropathy Charcot–Marie–
Tooth disease type 2D, and recent observations suggest
that GARS may colocalize with SMN in human cells (Motley
et al. 2010; Drew et al. 2011; Grice et al. 2015). Mouse
models of SMA exhibit disruptions to ubiquitin homeostasis,
and evidence of SMN interactions with proteasomal com-
ponents, including Psmd1, the mouse ortholog of Droso-
phila Rpn2 (Aghamaleky Sarvestany et al. 2014; Wishart
et al. 2014).
Despite our finding of splicing disruptions in genes of
known importance to SMA and neuromuscular biology in
severe loss-of-function mutants, these splicing changes
were absent from less severe models of SMA. Splicing pat-
terns are not conserved from flies to humans, and we would
not expect to find similar splicing disruptions in mammalian
models of SMA. Finding these genes at the top of our data set
maymerely reflect the sensitive nature of the splicing of genes
that are important for neuromuscular biology, and the fact
that transcriptome diversity is greatest in neuronal tissues, in-
cluding the brain (Mohr and Hartmann 2014).
Although we found evidence for both snRNP-dependent
and SMN-specific RNA changes in SMA models, it remains
to be determined which of these, if any, contributes to disease
pathology. Our analysis of severe and intermediate SMA
models suggests that snRNP-independent, Smn gene-specific
RNA changes may play a bigger role in SMA pathology than
previously envisioned. The SMN-specific activation of stress
FIGURE 9. Differential gene expression in Smn hypomorphic animals.
(A) Heatmap comparison of Cuffdiff FPKM levels of differentially ex-
pressed transcripts. Heatmap colors were rescaled for each row and
the rows were clustered based on pattern of gene expression between
SmnWT rescue line and the Smn missense mutants. (B) Venn diagram
of overlapping differences in mRNA levels. (C) A heatmap of FPKMs
from a set of stress-responsive transcripts. Genotypes are labeled by
SmnTg, which was expressed in the SmnX7 null background.
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signaling pathways is conserved in SMA models (Wu et al.
2011; Genabai et al. 2015) and correlates well with disease
severity in Smn hypomorphs (Fig. 8C). This activation of
stress signaling appears to be a common signature of neuro-
muscular disease (Deshpande and Rodal 2016).
Based on our finding of a potential activation in stress
signaling in fly models of SMA, an important question
moving forward will be to understand how loss of SMN
causes this stress response. By text mining with the stress
signatures identified in the SMA models described here,
we found that mutations in the Activating transcription factor
3 (Atf3) gene cause a similar dysregulation in immune and
metabolic homeostasis (Rynes et al. 2012). Among other
things, this signaling pathway appears to regulate the cyto-
solic formation of SMN-containing U-bodies in human cells
in response to bacterial pathogens (Tsalikis et al. 2015).
If SMN does indeed intersect with a normal host cell re-
sponse to bacteria, this would provide a parsimonious model
for the activation of stress signaling in SMA models, and an-
other avenue to explore potential connections to neuromus-
cular disease.
In conclusion, a direct comparison of snRNP biogenesis
mutants revealed that defects in snRNP supply cause com-
plex changes to the transcriptome. However, an analysis
of three different Smn hypomorphic lines showed that
RNA processing changes are unlikely to be the primary driv-
ers of SMA pathophysiology. Our studies support a model
of SMA etiology wherein general disruptions at the mRNA
level and specific disruptions at the SMN protein–protein
level are responsible for SMA phenotypes. In future ex-
periments, the key will be to uncover the tissue specific
molecular activities of SMN that are important for neuro-
muscular function. Ongoing work with these and other inter-
mediate models of SMA should help clarify the relative
contributions of the aforementioned factors to SMA pathol-
ogy and etiology.
MATERIALS AND METHODS
Fly mutants and husbandry
Stocks were cultured on molasses and agar at room temperature
(25 ± 1°C) in half-pint bottles. Oregon-R was used as the wild-type
allele. The SmnX7 microdeletion allele was a gift from S. Artava-
nis-Tsakonis (Harvard University, Cambridge, USA) (Chang
et al. 2008). Transposon insertion alleles SmnD ( f01109), Ars2C
(c00735), and Ars2E (e01128) were obtained from the Exelixis
collection at Harvard Medical School (Rajendra et al. 2007; Sabin
et al. 2009). The transposon insertion allele PhaxSH (P{lacW}
PhaxSH0641) was a gift from S. Hou (Oh et al. 2003).
The wild-type andmutant Smn transgenes are expressed using the
native Smn promoter. Transgenic constructs were integrated into
the PhiC31 landing site located at 86F8, which was previously re-
combined into an SmnX7 background (Praveen et al. 2012, 2014).
For RNA-seq analysis, Smn transgenes in the SmnX7 null back-
ground were crossed to SmnX7 animals, and trans-heterozygous an-
imals were put into TRIzol <12 h after pupation, as brown prepupa.
For qRT-PCR and developmental northerns, Smn transgenes in the
SmnX7 background were self-crossed, and homozygous animals
were put into TRIzol at 72–77 h post egg laying or <12 h after pu-
pation before air bubble migration.
For exogenous expression of a wild-type Phax transgene, an in-
tron-less Phax cDNA was subcloned into pBID-UASC-GV (Wang
et al. 2012), and subsequently injected and integrated into the
51C1 PhiC31 landing site by BestGene Inc. The UAS:Phax-mVenus
transgene at 51C1 was subsequently recombined into the PhaxSH
background. The armadillo promoter-GAL4 driver P{GAL4-arm.
S}11 (Sanson et al. 1996) was also recombined into the PhaxSH mu-
tant background.
RNA-seq and bioinformatics analyses
RNA was isolated from 74 ± 2-h-old wild-type and snRNP biogen-
esis mutant larvae by homogenization in TRIzol (Invitrogen), ac-
cording to the manufacturer’s protocol. Staged animals were
isolated from either the wandering third instar stage of development
or just before bubble migration in early tan pre-pupae (<12 h after
puparium formation). RNA was DNased with Amplification Grade
DNase I (Invitrogen) and TURBODNase (Ambion). A TruSeq RNA
Sample Preparation Kit v2 (Illumina) was used for: poly(A)-enrich-
ment or substituted here with Ribo-Zero (Epicentre) rRNA subtrac-
tion, barcoding for multiplexing, and cDNA library preparation.
Paired end (2 × 50) sequencing was performed on an Illumina
HiSeq 2000 platform. TopHat and Cufflinks were used for gene ex-
pression analyses, according to the bioinformatic pipeline from
Trapnell et al. (2012). DaPars was used to identify differences in
RNA length and alternative polyadenylation (Masamha et al.
2014; Xia et al. 2014). MISO (Katz et al. 2010) was used to measure
changes in annotated alternative-splicing events. For comparison,
we used a “strong” Bayes factor cutoff for our poly(A)-selected
RNA-seq analysis (Jeffreys 1961). We used a “positive” Bayes factor
as our cutoff for the total rRNA(−) RNA-seq analysis (Kass and
Raftery 1995). For developmental comparison, all publicly available
RNA-seq data from L2 to L3 puff stage 7–9 were downloaded from
the NCBI Sequence Read Archive (SRA) and converted to fastq for-
mat with the SRA toolkit (Graveley et al. 2011) (http://www.
modencode.org/). The heatmap was generated with the “pheatmap”
package from bioconductor (http://www.bioconductor.org).
Northern blotting
Northern analyses were performed using standard protocols
(Garcia et al. 2009). Briefly, RNA was isolated as indicated above
and ∼300 ng of total RNA was separated on 10% Novex TBE
Urea gels (Invitrogen), transferred to GeneScreen Plus charged ny-
lon membranes (PerkinElmer), dried, and UV cross-linked.
Northern blots were probed with 5′-end-labeled oligonucleotides
for the respective snRNAs, labeled with T4 polynucleotide kinase
(NEB) and [γ-32P]ATP (PerkinElmer). The snRNA-specific oligo-
nucleotide probe sequences are listed in Supplemental Table S22.
Hybridizations were performed at 65°C, and sequential washes in
2× SSC and 0.33× SSC were performed at 60°C. Damp blots were
exposed to storage phosphor screens (GE Healthcare) and analyzed
with a Typhoon TRIO+ (GE Healthcare). Bands were quantified us-
ing ImageQuant TL (GE Healthcare), and P-values for three
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biological replicates were determined with a one-tailed Student’s t-
test for unequal variance of two samples.
RT-PCR analysis
Semi-quantitative RT-PCR was performed with intron flanking oli-
gos, using the 2× Apex Taq Master Mix (Genesee Scientific).
Quantitative RT-PCR experiments were carried out as in Praveen
et al. (2012). Briefly, random hexamers were used to prime the re-
verse transcription of isolated RNA according to the manufacturers
protocol SupersScript III (Invitrogen). Real-time PCR reactions of
cDNA were carried out on a 7900HT Fast Real-time PCR machine
(Applied Biosystems), according to the Maxima SYBR Green/Rox
qPCR Master Mix (2×) (Thermo Scientific) two-step protocol.
Oligo pairs amplified cDNAs from intron inclusive versus spliced
mature mRNAs. Three biological replicates were tested for each ge-
notype. The ΔΔCt method was used to quantify differences, and P-
values were determined with a one-tailed Student’s t-test for un-
equal variance of two-samples. Gene-specific primer sequences
are listed in Supplemental Table S22.
Western blotting
Western analyses were performed using standard protocols and
modifications to the methods of Praveen et al. (2012). Briefly, larval
protein lysates were prepared by crushing the animals in lysis buffer
(50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP-
40, 0.1% SDS, 1% deoxycholate) with 5× protease inhibitor cocktail
(Invitrogen) and clearing the lysate by centrifugation. The anti-
dUTPase antibody was a generous gift from B.G. Vértessy, and it
was used at a dilution of 1 to 50,000 (Békési et al. 2004). Affinity pu-
rified anti-dSMN was used at a 1 to 2500 dilution (Praveen et al.
2012). Anti-α-tubulin antibody (Sigma) was used at a 1 to 50,000
dilution.
Cell culture and RNAi
The S2 cell line was obtained from the Drosophila Genome
Resource Center and cultivated according to published protocols
(Rogers and Rogers 2008). Gene-specific RNAi knockdown was
also performed as described in Rogers and Rogers (2008). Briefly,
S2 cells were maintained in Sf-900 II SFM media (Gibco) supple-
mented with 1× Pen Strep (Gibco). For RNAi, 1 mL of (1 × 106
cells/mL) was aliquoted into each well of a six-well tissue culture
plate. Double-stranded RNA (dsRNA) was in vitro transcribed over-
night (∼16 h) from PCR templates with the T7 MEGAscript kit
(Invitrogen), and dsRNA products were subsequently treated with
TURBO DNase (Ambion), according to the respective manufactur-
ers’ protocols. Oligonucleotide sequences for amplifying the PCR
templates are listed in Supplemental Table S22. PCR templates
were amplified from the following plasmids: Smn, pAFW-SMN;
Prp6/CG6841, cDNA clone OFa18909 (GenScript); or Prp8, cDNA
clone OFa09689 (GenScript). Purified dsRNA was phenol–chloro-
form extracted, ethanol precipitated, resuspended in RNase-free wa-
ter (Ambion), and quantified by spectrophotometer. Approximately
15 μg of dsRNAwas added to 1 × 106 cells per each well of a six-well
plate. The dsRNAwas added once each day for three successive days.
On the fourth day, cells were pelleted and resuspended in TRIzol
(Invitrogen). RNA and proteins were extracted according to the
manufacturer’s protocol.
DATA DEPOSITION
The poly(A)-RNA-seq of wild-type Oregon-R and Smn null animals
were deposited in the NCBI Gene Expression Omnibus (Edgar
et al. 2002) and are accessible through GEO Series accession num-
ber GSE49587 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE49587). The additional data discussed in this publication
are accessible through GEO Series accession number GSE81121
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81121).
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Supplemental material is available for this article.
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